KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Minority Interest (2016 - 2026)

Bristol Myers Squibb has reported Minority Interest over the past 18 years, most recently at $34.0 million for Q1 2026.

  • Quarterly Minority Interest fell 42.37% to $34.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $34.0 million through Mar 2026, down 42.37% year-over-year, with the annual reading at $33.0 million for FY2025, 37.74% down from the prior year.
  • Minority Interest was $34.0 million for Q1 2026 at Bristol Myers Squibb, up from $33.0 million in the prior quarter.
  • Over five years, Minority Interest peaked at $65.0 million in Q1 2022 and troughed at $33.0 million in Q4 2025.
  • The 5-year median for Minority Interest is $57.0 million (2022), against an average of $55.0 million.
  • Year-over-year, Minority Interest rose 1.72% in 2025 and then crashed 42.37% in 2026.
  • A 5-year view of Minority Interest shows it stood at $57.0 million in 2022, then fell by 3.51% to $55.0 million in 2023, then dropped by 3.64% to $53.0 million in 2024, then tumbled by 37.74% to $33.0 million in 2025, then rose by 3.03% to $34.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Minority Interest are $34.0 million (Q1 2026), $33.0 million (Q4 2025), and $48.0 million (Q3 2025).